Belpointe Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Belpointe Asset Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,175	Closed	-$16.1K	–	773
2023 Q3	$16.1K	Hold	11,175	–	–	﹤0.01%	648
2023 Q2	$29.1K	Sell	11,175 -55,000	-83%	-$164K	﹤0.01%	607
2023 Q1	$244K	Sell	66,175 -7,375	-10%	-$31.1K	0.01%	843
2022 Q4	$130K	Sell	73,550 -6,800	-8%	-$18.1K	0.01%	1102
2022 Q3	$318K	Buy	80,350 +3,475	+5%	+$21.4K	0.02%	668
2022 Q2	$426K	Buy	76,875 +16,700	+28%	+$137K	0.03%	554
2022 Q1	$883K	Hold	60,175	–	–	0.05%	377
2021 Q4	$951K	Buy	60,175 +5,375	+10%	+$129K	0.06%	329
2021 Q3	$1.76M	Sell	54,800 -1,926	-3%	-$67.7K	0.12%	176
2021 Q2	$2.36M	Sell	56,726 -760	-1%	-$31.2K	0.17%	126
2021 Q1	$2.92M	Buy	57,486 +3,000	+6%	+$157K	0.25%	79
2020 Q4	$1.77M	Buy	54,486 +45,000	+474%	+$638K	0.16%	143
2020 Q3	$113K	Hold	9,486	–	–	0.01%	734
2020 Q2	$125K	Buy	+9,486	New	+$124K	0.02%	656

Other funds holding DMTK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Belpointe Asset Management's DMTK Position: Q4 2023 in Review

Belpointe Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2023, closing a stake of 11,175 shares — an estimated $16.1K sold.

Belpointe Asset Management first reported a position in DMTK in Q2 2020 and held it in 14 quarters. The position peaked at $2.92M in Q1 2021. 77 funds tracked by Wall St. Rank hold DMTK as of Q4 2023.

Belpointe Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Belpointe Asset Management sold 11,175 DermTech, Inc. Common Stock shares in Q4 2023, an estimated $16.1K.
Belpointe Asset Management first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
Belpointe Asset Management's DermTech, Inc. Common Stock position peaked at $2.92M in Q1 2021.
77 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2023.

Based on Belpointe Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.